Product Information

DARIFENACIN ER 15 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4819 per EA under NDC 33342027707. Its NADAC has been published 453 times since Mar 14, 2018.

FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DARIFENACIN ER 15 MG TABLET

Darifenacin
$0.4819per EA

Strength

15 mg/1

NDC

33342027707

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DARIFENACIN HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207302

FDA Approved

7/28/2017

TE Code

AB

On Market Since

7/29/2017

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for DARIFENACIN ER 15 MG TABLET has been published 453 times since Mar 14, 2018, and over the history we have for it it has declined 92.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4819 per EA
All-time high$6.3836 (Mar 14, 2018)
All-time low$0.3150 (Mar 19, 2025)
52-week high$0.4819
52-week low$0.3715
Median price$1.5389
Average price$1.9862
Largest weekly change+137.4% (Jun 23, 2021)
Weeks tracked453
Tracking sinceMar 14, 2018

Price History

1W

0.0%

1M

+11.5%

3M

+21.3%

6M

+13.5%

1Y

+37.8%

3Y

-68.7%

5Y

-77.2%

All

-92.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DARIFENACIN ER 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 15 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.4819 per EA (NDC 33342027707), effective Nov 11, 2026.

How has the price of DARIFENACIN ER 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for DARIFENACIN ER 15 MG TABLET has declined 92.5%. It has been tracked across 453 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 15 MG TABLET?

Since Mar 14, 2018, the NADAC for DARIFENACIN ER 15 MG TABLET has ranged from a low of $0.3150 (Mar 19, 2025) to a high of $6.3836 (Mar 14, 2018), with a median of $1.5389 per EA.

Are there cheaper alternatives to DARIFENACIN ER 15 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DARIFENACIN ER 15 MG TABLET, is $0.4394 per EA — about 9% below DARIFENACIN ER 15 MG TABLET.

Who manufactures DARIFENACIN ER 15 MG TABLET?

DARIFENACIN ER 15 MG TABLET (NDC 33342027707) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.